GlaxoSmithKline plc (NYSE:GSK) Q1 2022 Results Conference Call April 27, 2022 7:00 AM ET Company Participants Nick Stone - Head of Global Investor Relations Emma Walmsley - Chief Executive Officer Iain Mackay - Chief Financial Officer Deborah Waterhouse - Chief Executive Officer, ViiV Healthcare Brian McNamara - Chief Executive Officer, GSK Consumer Health Luke Miels - Chief Commercial Officer Roger Connor - President, Vaccine and Global Health Hal Barron - Chief Scientific Officer Conference Call Participa ...

27 April 2022 Q1 2022 results Cautionary statement regarding forward-looking statements This presentation may contain forward-looking statements. Forward-looking statements give the Group's current expectations or forecasts of future events. An investor can identify these statements by the fact that they do not relate strictly to historical or current facts. They use words such as 'anticipate', 'estimate', 'expect', 'intend', 'will', 'project', 'plan', 'believe', 'target' and other words and terms of simila ...